Orthosiphon aristatus (Blume) Miq alleviates non-alcoholic fatty liver disease via antioxidant activities in C57BL/6 obese mice and palmitic–oleic acid-induced steatosis in HepG2 Cells

[thumbnail of pharmaceuticals-16-00109-v2.pdf]
Preview
pharmaceuticals-16-00109-v2.pdf - Published Version (10MB) | Preview
Available under license: Creative Commons Attribution

Alshehade, Salah Abdalrazak ORCID: 0000-0001-8732-1883, Al Zarzour, Raghdaa, Mathai, Michael ORCID: 0000-0001-8783-2122, Giribabu, Nelli, Seyedan, Atefehalsadat, Kaur, Gurjeet ORCID: 0000-0002-6232-5703, Al-Suede, Fuoad Saleih Resq ORCID: 0000-0003-1816-6722, Majid, Amin Malik Shah Abdul, Murugaiyah, Vikneswaran ORCID: 0000-0003-1768-7577, Almoustafa, Hassan ORCID: 0000-0002-2549-1761 and Alshawsh, Mohammed Abdullah ORCID: 0000-0001-8342-5183 (2023) Orthosiphon aristatus (Blume) Miq alleviates non-alcoholic fatty liver disease via antioxidant activities in C57BL/6 obese mice and palmitic–oleic acid-induced steatosis in HepG2 Cells. Pharmaceuticals, 16 (1). ISSN 1424-8247

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of liver disease. Orthosiphon aristatus (Blume) Miq, a traditional plant in South Asia, has previously been shown to attenuate obesity and hyperglycaemic conditions. Eight weeks of feeding C57BL/6 mice with the standardized O. aristatus extract (400 mg/kg) inhibited the progression of NAFLD. Liver enzymes including alanine aminotransferase and aspartate transaminase were significantly reduced in treated mice by 74.2% ± 7.69 and 52.8% ± 7.83, respectively. Furthermore, the treated mice showed a reduction in serum levels of glucose (50% ± 5.71), insulin (70.2% ± 12.09), total cholesterol (27.5% ± 15.93), triglycerides (63.2% ± 16.5), low-density lipoprotein (62.5% ± 4.93) and atherogenic risk index relative to the negative control. Histologically, O. aristatus reversed hepatic fat accumulation and reduced NAFLD severity. Notably, our results showed the antioxidant activity of O. aristatus via increased superoxide dismutase activity and a reduction of hepatic malondialdehyde levels. In addition, the levels of serum pro-inflammatory mediators (IL-6 and TNFα) decreased, indicating anti-inflammatory activity. The aqueous, hydroethanolic and ethanolic fractions of O. aristatus extract significantly reduced intracellular fat accumulation in HepG2 cells that were treated with palmitic–oleic acid. Together, these findings suggest that antioxidant activities are the primary mechanism of action of O. aristatus underlying the anti-NAFLD effects.

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/46959
DOI 10.3390/ph16010109
Official URL https://www.mdpi.com/1424-8247/16/1/109
Subjects Current > FOR (2020) Classification > 3214 Pharmacology and pharmaceutical sciences
Current > Division/Research > College of Health and Biomedicine
Keywords non-alcoholic fatty liver disease, NAFLD, liver disease, antioxidants
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login